SVRA Stock Analysis: Buy, Sell, or Hold?
SVRA - Savara Inc.
$5.56
-0.02 (-0.36%)
▼
5d:
+5.9%
30d:
-1.07%
90d:
-7.79%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
SVRA is down 6.5% this week, but smart money is accumulating calls. Top strike: $7.5 2026-05-15 with 338 OI. Call ratio: 100% View Scanner →
Strength: 8.2/10
Get Alerted When SVRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SVRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SVRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SVRA is currently trading at $5.56, which is considered fair relative to its 30-day fair value range of $5.11 to $5.72.
Technical Outlook: Technically, SVRA is in a strong uptrend. The price is approaching resistance at $5.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SVRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.81 (+94.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SVRA is in a strong uptrend. The price is approaching resistance at $5.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SVRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.81 (+94.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.11 -
$5.72
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 94.5% below Wall St target ($10.81)
Fair Price Analysis
30-Day Fair Range
$5.11 -
$5.72
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$4.81
Resistance Level
$5.70
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.38
Wall Street Target
$10.81
(+94.5%)
Share & Embed Analysis
Last updated: April 06, 2026 12:14 AM ET
Data refreshes hourly during market hours. Next update: 1:14 AM
Data refreshes hourly during market hours. Next update: 1:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SVRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 63 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$50 | 54 HOLD |